Baseline genetic abnormalities and effectiveness of osimertinib treatment in patients with chemotherapy-naïve EGFR-mutated NSCLC based on performance status
基于体能状态的基线基因异常和奥希替尼治疗对未接受化疗的EGFR突变型非小细胞肺癌患者的疗效
期刊:BMC Pulmonary Medicine
影响因子:2.8
doi:10.1186/s12890-024-03212-5
Taniguchi, Yoshihiko; Tamiya, Akihiro; Osuga, Mitsuo; Harada, Daijiro; Isa, Shun-Ichi; Nakamura, Keiichi; Mizumori, Yasuyuki; Shinohara, Tsutomu; Yanai, Hidetoshi; Nakatomi, Katsumi; Oki, Masahide; Mori, Masahide; Kuwako, Tomohito; Yamazaki, Koji; Tamura, Atsuhisa; Ando, Masahiko; Koh, Yasuhiro